Non‑melanoma skin cancer - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Non‑melanoma Skin Cancer – Complete Medical Guide

Non‑melanoma Skin Cancer – A Comprehensive Medical Guide

Overview

Non‑melanoma skin cancer (NMSC) is a group of cancers that arise from the keratin‑producing cells of the epidermis. The two most common types are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Unlike melanoma, which develops from melanocytes, NMSC usually grows slowly and rarely spreads (metastasizes) when caught early.

Who it affects: NMSC can occur at any age, but the incidence rises sharply after age 50. Men are slightly more likely than women to develop BCC, while SCC shows a more balanced gender distribution. People with fair skin, a history of extensive sun exposure, or a weakened immune system are at highest risk.

Prevalence: In the United States, more than 5 million cases of NMSC are diagnosed each year – roughly 1 in 5 Americans will develop one in their lifetime [CDC, 2022]. Worldwide, the incidence mirrors patterns of ultraviolet (UV) radiation exposure, with higher rates in regions near the equator and in countries with large outdoor workforces.

Symptoms

Early detection relies on recognizing subtle skin changes. Below is a comprehensive list of signs for BCC and SCC, noting that many lesions can be painless.

Basal Cell Carcinoma (BCC)

  • Pearl‑like nodule: Shiny, smooth bump often with visible blood vessels.
  • Pink, red, or brown patch: May look like a scar or eczema.
  • Ulcerated lesion: Central crater that bleeds or crusts.
  • Rolled border: Edge that feels raised and “rolled” compared with surrounding skin.
  • Tenderness or bleeding after minor trauma.

Squamous Cell Carcinoma (SCC)

  • Scaly, rough patch: Often reddish or tan, may feel sandpaper‑like.
  • Open sore that does not heal within 3–4 weeks.
  • Raised nodule with a central ulcer.
  • Red or white crust that can bleed.
  • Rapid growth compared with surrounding skin.

Both BCC and SCC can appear on sun‑exposed areas—face, ears, neck, scalp, hands, and forearms—but SCC also frequently arises on chronic wounds or scar tissue (Marjolin ulcer).

Causes and Risk Factors

Non‑melanoma skin cancer is primarily driven by DNA damage from ultraviolet radiation. However, a combination of intrinsic and extrinsic factors contributes to risk.

Primary Causes

  • Ultraviolet (UV) radiation – both UVA (aging) and UVB (DNA mutation) wavelengths. Cumulative exposure is the greatest danger.
  • Ionizing radiation – therapeutic radiation for other cancers can precipitate NMSC years later.
  • Human papillomavirus (HPV) infection – especially high‑risk types for SCC on the genitalia, perianal area, and oral mucosa.

Key Risk Factors

  • Skin type: Fitzpatrick skin types I–II (very fair, always burn, never tan).
  • Age: Risk doubles approximately every decade after age 40.
  • Sex: Men have a slightly higher BCC rate; occupational exposure partly explains this.
  • Geographic location: Higher altitude and latitude close to the equator = more UV.
  • Personal or family history of skin cancer.
  • Immunosuppression: Organ‑transplant recipients have a 65‑fold increased SCC risk [NIH, 2018].
  • Chronic wounds, burns, or scars (e.g., burn scars, longstanding ulcerations).
  • Exposure to certain chemicals: Arsenic, tar, coal tars, and some industrial solvents.
  • Tanning bed use: Emits UVA radiation; associated with a 20‑30% higher BCC risk.

Diagnosis

Early and accurate diagnosis allows for less invasive treatment.

Clinical Examination

  • Visual inspection by a dermatologist using dermoscopy (a handheld magnifying device).
  • Full‑body skin check for additional lesions, especially in high‑risk patients.

Biopsy Techniques

  1. Punch biopsy: Small circular blade removes a core of tissue; most common for suspected NMSC.
  2. Excisional biopsy: Entire lesion removed with a margin of normal skin; preferred when the lesion is small (<1 cm) and clearly defined.
  3. Shave biopsy: Superficial slice; may be used for raised lesions but can miss deeper invasion.

Pathology

The specimen is evaluated by a dermatopathologist. Staging (for SCC) follows the AJCC 8th edition criteria, which consider tumor size, depth of invasion, perineural involvement, and location.

Additional Tests (when indicated)

  • Imaging (CT, MRI, PET) for high‑risk SCC with suspected deep invasion or metastasis.
  • Sentinel lymph node biopsy for select SCCs (≥2 cm, high‑grade histology) to assess regional spread.

Treatment Options

Management is individualized based on tumor type, size, location, patient health, and cosmetic considerations.

Procedural Treatments

  • Standard surgical excision: Removal with 4‑6 mm margins for BCC and 6‑10 mm for SCC. Offers the highest cure rate (>95%).
  • Mohs micrographic surgery: Tissue is removed layer‑by‑layer and examined intra‑operatively. Ideal for high‑risk sites (nose, eyelids, ears) or recurrent tumors; cure rates exceed 99% [Cleveland Clinic].
  • Curettage & electrodessication (C&E): Scraping the tumor followed by cauterization; suitable for low‑risk, small BCCs.
  • Laser therapy (CO₂ or erbium‑YAG): Used for superficial BCCs and some SCC in situ.
  • Topical therapies:
    • 5% fluorouracil cream – DNA synthesis inhibitor, applied twice daily for 3‑4 weeks.
    • Imiquimod 5% cream – immune response modifier, used for superficial BCC or actinic keratoses.
  • Photodynamic therapy (PDT): Application of a photosensitizer (e.g., aminolevulinic acid) followed by light activation; effective for superficial BCC and SCC in situ.
  • Radiation therapy: Considered for patients who cannot undergo surgery, or for large, infiltrative tumors.

Systemic Therapies (advanced disease)

  • Hedgehog pathway inhibitors (vismodegib, sonidegib) – FDA‑approved for locally advanced or metastatic BCC [Mayo Clinic].
  • Immune checkpoint inhibitors (cemiplimab, pembrolizumab) – Shown to shrink advanced SCC and improve survival.
  • Chemotherapy – Rarely used nowadays; may be considered in combination with radiation for metastatic disease.

Lifestyle & Supportive Measures

  • Daily sunscreen use (SPF 30+ broad‑spectrum).
  • Protective clothing, hats, and sunglasses.
  • Smoking cessation – smoking impairs wound healing and raises SCC risk.
  • Regular skin self‑exams and professional dermatologic surveillance.

Living with Non‑melanoma Skin Cancer

Even after successful treatment, ongoing care is essential to detect recurrences and maintain skin health.

Follow‑up Schedule

  • Low‑risk BCC: Every 6–12 months for the first 2 years, then annually.
  • High‑risk BCC or SCC: Every 3–6 months for the first 3 years, then annually.

Skin Care Routine

  • Gentle, fragrance‑free cleansers; avoid abrasive scrubs on surgical sites.
  • Moisturize regularly to prevent dryness that can mimic lesions.
  • Apply silicone gel sheets or scar‑reduction creams if cosmetically concerned.

Psychosocial Aspects

Visible lesions or surgical scars can affect self‑image. Consider counseling, support groups, or referral to a dermatologist experienced in cosmetic reconstruction.

Activity Modifications

  • Plan outdoor activities before 10 am and after 4 pm when UV intensity is lower.
  • Use UV‑protective sunscreen on all exposed skin, reapplying every 2 hours and after swimming or sweating.
  • Wear UPF‑rated clothing; a wide‑brimmed hat protects the scalp and face.

Prevention

Most NMSC cases are preventable with consistent sun‑safety habits.

Sun‑Protection Strategies

  1. Daily sunscreen: Broad‑spectrum SPF 30‑50; apply 15 minutes before exposure.
  2. Seek shade whenever UV index >3, especially between 10 am–4 pm.
  3. Protective clothing: Long‑sleeved shirts, trousers, wide‑brim hat, and UV‑blocking sunglasses.
  4. Avoid indoor tanning: Neither “safe” nor regulated for UV output.

Regular Dermatologic Screening

High‑risk individuals (history of NMSC, immunosuppressed, organ‑transplant recipients, or >50 years with extensive sun exposure) should have a full skin exam by a dermatologist at least once a year.

Chemical & Occupational Precautions

  • Use protective equipment when handling arsenic, coal tar, or industrial solvents.
  • Employ sunscreen or protective sleeves for outdoor workers; encourage employers to provide shade breaks.

Complications

When NMSC is left untreated or inadequately treated, several complications may arise.

  • Local tissue destruction: Large or infiltrative BCC can erode bone, cartilage, or eyes.
  • Metastasis: Rare in BCC (<0.1%) but more common in SCC (up to 5% for high‑risk tumors) and can spread to lymph nodes, lungs, or liver.
  • Functional impairment: Tumors on the eyelids, lips, or ears may affect vision, speech, or hearing.
  • Scarring and disfigurement: May lead to psychological distress and reduced quality of life.
  • Second primary skin cancers: Having one NMSC dramatically increases the odds of developing additional lesions (≈30% within 5 years) [CDC, 2022].

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:
  • Rapidly expanding ulcer or lesion that bleeds profusely.
  • Severe pain, swelling, or warmth around a skin cancer that suggests infection (cellulitis) or necrosis.
  • Difficulty breathing, swallowing, or seeing caused by a lesion on the face, throat, or near the eye.
  • Sudden onset of a large lump in a lymph node (especially in the neck) accompanied by fever or night sweats.
  • Unexplained weight loss, persistent fatigue, or generalized weakness in a patient with known advanced skin cancer.

These signs may indicate an infection, aggressive disease progression, or metastatic spread that requires immediate medical intervention.

References

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References